172 related articles for article (PubMed ID: 3121351)
1. Serum amyloid A protein compared with C-reactive protein, alpha 1-antichymotrypsin and alpha 1-acid glycoprotein as a monitor of inflammatory bowel disease.
Chambers RE; Stross P; Barry RE; Whicher JT
Eur J Clin Invest; 1987 Oct; 17(5):460-7. PubMed ID: 3121351
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.
Niederau C; Backmerhoff F; Schumacher B; Niederau C
Hepatogastroenterology; 1997; 44(13):90-107. PubMed ID: 9058126
[TBL] [Abstract][Full Text] [Related]
3. Serum amyloid-A protein concentration in rheumatoid arthritis and its role in monitoring disease activity.
Chambers RE; MacFarlane DG; Whicher JT; Dieppe PA
Ann Rheum Dis; 1983 Dec; 42(6):665-7. PubMed ID: 6651371
[TBL] [Abstract][Full Text] [Related]
4. Microheterogeneity of acute phase proteins in patients with ulcerative colitis.
Grzymisławski M; Derc K; Sobieska M; Wiktorowicz K
World J Gastroenterol; 2006 Aug; 12(32):5191-5. PubMed ID: 16937531
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of serum procalcitonin in determining the activity of inflammatory bowel disease.
Oruç N; Ozütemiz O; Osmanoğlu N; Ilter T
Turk J Gastroenterol; 2009 Mar; 20(1):9-12. PubMed ID: 19330729
[TBL] [Abstract][Full Text] [Related]
7. [The usefulness of reactive protein C in managing patients with ulcerative colitis and Crohn's disease].
López Morante AJ; Sáez-Royuela F; Yuguero del Moral L; Martín Lorente JL; Ojeda Giménez C
Rev Esp Enferm Dig; 1993 Jan; 83(1):5-9. PubMed ID: 8452705
[TBL] [Abstract][Full Text] [Related]
8. [Acute-phase proteins and beta 2 microglobulin in the follow-up of Crohn disease and ulcerative colitis].
Bollbach R; Rotthauwe HW
Klin Padiatr; 1985; 197(2):106-10. PubMed ID: 3887012
[TBL] [Abstract][Full Text] [Related]
9. Serum concentration of 19 serum proteins in Crohn's disease and ulcerative colitis.
Weeke B; Jarnum S
Gut; 1971 Apr; 12(4):297-302. PubMed ID: 4102485
[TBL] [Abstract][Full Text] [Related]
10. CRP correlates with clinical score in ulcerative colitis but not in Crohn's disease.
Rodgers AD; Cummins AG
Dig Dis Sci; 2007 Sep; 52(9):2063-8. PubMed ID: 17436102
[TBL] [Abstract][Full Text] [Related]
11. Peripheral blood monocyte cytokine production and acute phase response in inflammatory bowel disease.
Mazlam MZ; Hodgson HJ
Gut; 1992 Jun; 33(6):773-8. PubMed ID: 1624158
[TBL] [Abstract][Full Text] [Related]
12. Laboratory assessment of disease activity in childhood Crohn's disease and ulcerative colitis.
Macfarlane PI; Miller V; Wells F; Richards B
J Pediatr Gastroenterol Nutr; 1986 Jan; 5(1):93-6. PubMed ID: 3944748
[TBL] [Abstract][Full Text] [Related]
13. [Serum acute phase proteins for determining disease activity of ulcerative colitis and Crohn disease].
Vucelić B; Milicić D; Krznarić Z; Korać B; Sentić M; Hadzić N; Stavljenić A; Cvorisćec D
Acta Med Austriaca; 1991; 18(4):100-5. PubMed ID: 1722373
[TBL] [Abstract][Full Text] [Related]
14. Interrelations between interleukin-6, interleukin-1 beta, plasma C-reactive protein values, and in vitro C-reactive protein generation in patients with inflammatory bowel disease.
Mazlam MZ; Hodgson HJ
Gut; 1994 Jan; 35(1):77-83. PubMed ID: 8307455
[TBL] [Abstract][Full Text] [Related]
15. Raised serum activity of phospholipase A2 immunochemically related to group II enzyme in inflammatory bowel disease: its correlation with disease activity of Crohn's disease and ulcerative colitis.
Minami T; Tojo H; Shinomura Y; Tarui S; Okamoto M
Gut; 1992 Jul; 33(7):914-21. PubMed ID: 1644331
[TBL] [Abstract][Full Text] [Related]
16. [Neopterin in assessing the activity of inflammatory bowel diseases: ulcerative colitis and Crohn's disease].
Ciećko-Michalska I; Fedak D; Mach T
Przegl Lek; 2010; 67(12):1262-5. PubMed ID: 21591350
[TBL] [Abstract][Full Text] [Related]
17. Microheterogeneity of acute-phase glycoproteins in patients with pulmonary sarcoidosis.
Hrycaj P; Wurm K; Mennet P; Müller W
Eur Respir J; 1996 Feb; 9(2):313-8. PubMed ID: 8777970
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis.
Fagan EA; Dyck RF; Maton PN; Hodgson HJ; Chadwick VS; Petrie A; Pepys MB
Eur J Clin Invest; 1982 Aug; 12(4):351-9. PubMed ID: 6814926
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-1 receptor antagonist in differential diagnosis of inflammatory bowel diseases.
Propst A; Propst T; Herold M; Vogel W; Judmaier G
Eur J Gastroenterol Hepatol; 1995 Nov; 7(11):1031-6. PubMed ID: 8680901
[TBL] [Abstract][Full Text] [Related]
20. The insulin-like growth factor system and markers of inflammation in adult patients with inflammatory bowel disease.
Eivindson M; Nielsen JN; Grønbaek H; Flyvbjerg A; Hey H
Horm Res; 2005; 64(1):9-15. PubMed ID: 16088202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
